Kronos Bio, Inc. Proceeds from Common Stock Issued
Kronos Bio, Inc. reported Proceeds from Common Stock Issued of $471.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-15.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2023-03-15
- Kronos Bio, Inc. proceeds from issuance of common stock for the quarter ending 2021-03-31 was $590.00K, a 2850.00% increase year-over-year.
- Kronos Bio, Inc. proceeds from issuance of common stock for the quarter ending 2020-12-31 was $234.00K, a 296.61% increase year-over-year.
- Kronos Bio, Inc. proceeds from issuance of common stock for the quarter ending 2020-03-31 was $20.00K.
- Kronos Bio, Inc. proceeds from issuance of common stock for the quarter ending 2019-12-31 was $59.00K.
- Kronos Bio, Inc. proceeds from issuance of common stock for fiscal 2022 was $471.00K, a 84.94% decline from fiscal 2021.
- Kronos Bio, Inc. proceeds from issuance of common stock for fiscal 2021 was $3.13M, a 384.81% increase from fiscal 2020.
- Kronos Bio, Inc. proceeds from issuance of common stock for fiscal 2020 was $645.00K, a 460.87% increase from fiscal 2019.
- Kronos Bio, Inc. proceeds from issuance of common stock for fiscal 2019 was $115.00K, a 2200.00% increase from fiscal 2018.
| Period end | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 12 month |
|---|---|---|---|---|
| 2022-12-31 | $471.00K 10-K · filed 2023-03-15 | |||
| 2021-12-31 | $3.13M 10-K · filed 2023-03-15 | |||
| 2021-03-31 | $590.00K 10-Q · filed 2021-05-11 | $824.00K derived: sum of 2 quarters · filed 2022-02-24 | ||
| 2020-12-31 | $234.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $645.00K 10-K · filed 2022-02-24 | ||
| 2020-09-30 | $411.00K 10-Q · filed 2020-11-18 | |||
| 2020-03-31 | $20.00K 10-Q · filed 2021-05-11 | $79.00K derived: sum of 2 quarters · filed 2022-02-24 | ||
| 2019-12-31 | $59.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $115.00K 10-K · filed 2022-02-24 | ||
| 2019-09-30 | $56.00K 10-Q · filed 2020-11-18 | |||
| 2018-12-31 | $5.00K 10-K · filed 2021-03-23 |